STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug
2026-10-09 15:41
634 views
Adobe
By Meghana Keshavan and Jason MastOct. 9, 2026
Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter.Jason Mast[email protected]Jason is a ge...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
This is the Readout. Please read it.
And don’t miss us too much Monday, when the newsletter will be paused for the holiday. We’ll be back in your inbox Tuesday.
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.